| P50 | author | Andrew H. Sims | Q39065426 |
| | Richard Meehan | Q42846183 |
| | David Harrison | Q56737485 |
| | Jean A Quinn | Q63366499 |
| P2093 | author name string | J Li | |
| | E E Evans | |
| | S P Langdon | |
| | E Katz | |
| | S Dubois-Marshall | |
| | E S Smith | |
| | M Edward | |
| | D Faratian | |
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| | The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells | Q24290151 |
| | The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells | Q24317705 |
| | Significance analysis of microarrays applied to the ionizing radiation response | Q24606608 |
| | MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture | Q24646310 |
| | AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist | Q24652842 |
| | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 |
| | The EGF receptor family: spearheading a merger of signaling and therapeutics | Q28289369 |
| | X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization | Q80980462 |
| | Keratinocyte regulation of TGF-beta and connective tissue growth factor expression: a role in suppression of scar tissue formation | Q81522497 |
| | Breaking down EMT | Q81556375 |
| | Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics | Q28751743 |
| | Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures | Q29547700 |
| | Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 |
| | beadarray: R classes and methods for Illumina bead-based data. | Q31116642 |
| | Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo | Q33510688 |
| | Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer | Q33676758 |
| | R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation | Q34562439 |
| | HER-2 and topoisomerase II as predictors of response to chemotherapy | Q34747499 |
| | An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors | Q35024308 |
| | Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors | Q35906418 |
| | Modelling glandular epithelial cancers in three-dimensional cultures | Q36251934 |
| | Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer | Q36443026 |
| | SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma | Q36445884 |
| | The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. | Q36667053 |
| | American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q36678853 |
| | The many faces of ITAMs. | Q36695974 |
| | Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells. | Q37459500 |
| | The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer | Q37630052 |
| | The genomic profile of HER2-amplified breast cancers: the influence of ER status | Q38360582 |
| | Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells. | Q39841601 |
| | Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases | Q39882808 |
| | GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation | Q40071931 |
| | The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein | Q40169132 |
| | Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells | Q40198105 |
| | RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes | Q40278421 |
| | Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells | Q40326039 |
| | Dangers of using "optimal" cutpoints in the evaluation of prognostic factors | Q40752297 |
| | C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer | Q42604307 |
| | Cellular ITAM-containing proteins are oncoproteins in nonhematopoietic cells. | Q42806816 |
| | Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation | Q42828149 |
| | The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents | Q44453360 |
| | Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. | Q45917372 |
| | A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial | Q46236782 |
| | Automated subcellular localization and quantification of protein expression in tissue microarrays. | Q52030096 |
| | Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. | Q53347753 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amplicon | Q2844457 |
| P304 | page(s) | 401-410 | |
| P577 | publication date | 2010-07-13 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk | |
| P478 | volume | 103 | |